NextCell publishes its Interim Report 1 2023/2024
NextCell Pharma AB (publ) (NXTCL or NextCell) publishes its Interim Report 1 for the period September 1, 2023 – November 30, 2023. The report is available on the company’s website: https://www.nextcellpharma.com/en/investors#financial-report. NextCells share is traded on Nasdaq First North Growth Market under the ticker "NXTCL". The amount in brackets refers to the corresponding period in the previous year.First quarter (2023-09-01 until 2023-11-30) ● Operating Income amounted to 4,695 (3,012) TSEK, of which Cellaviva amounted to 4,218 (2,137) TSEK.● Operating result amounted to -9,